<div class="accordion__content" style="display: none;" id="dom13331-supInfo-0001" aria-hidden="false">
               <div class="support-info__table-wrapper article-table-content-wrapper">
                  
                  
                  <table class="support-info__table table article-section__table">
<thead><tr>
<th id="article-filename" scope="col">Filename</th>
                        <th id="article-description" scope="col">Description</th>
                     </tr></thead>
<tbody><tr id="dom13331-supitem-0001">
<td headers="article-filename">
<a href="https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1111%2Fdom.13331&amp;file=dom13331-sup001-AppendixS1.docx">dom13331-sup001-AppendixS1.docx</a>Word 2007 document
            , 139.2 KB
                           </td>
                           <td headers="article-description">
                              <p>Appendix S1.Further reading on diabetes treatments in elderly patients with type 2 diabetes.</p>
                              <p>Table S1. Trial design of the phase 3a SUSTAIN 1─5 trials.</p>
                              <p>Table S2. Gastrointestinal adverse events by age group in SUSTAIN 1–5</p>
                              <p>Table S3. Gastrointestinal adverse events leading to premature treatment discontinuation in SUSTAIN 1–5 pool</p>
                              <p>Table S4. EAC‐confirmed events by age group in SUSTAIN 1–5 pool</p>
                              <p>Table S5. Change from baseline in renal function in SUSTAIN 1–5 pool</p>
                              <p>Figure S1. Patients achieving HbA1c target &lt;7.0% at end of treatment by age group in SUSTAIN 1–5</p>
                              <p>Figure S2. Patients with body weight loss ≥5% at end of treatment by age group in SUSTAIN 1–5</p>
                              <p>Figure S3. Adverse events summary: pooled data by age group from SUSTAIN 1–5</p>
                              <p>Figure S4. Rate of severe or 
BG‐confirmed hypoglycaemia events by age group in SUSTAIN 1–5 (A) and in
 patients on SU/not on SU in SUSTAIN 3 and SUSTAIN 4 (B)</p>
                              
                           </td>
                        </tr></tbody>
</table>
<p class="disclaimer_text">Please note: The publisher 
is not responsible for the content or functionality of any supporting 
information supplied by the authors. Any queries (other than missing 
content) should be directed to the corresponding author for the article.</p>
               </div>
            </div>